The inflammation-fighting drug celecoxib prevents some outbreaks of skin cancer in people genetically predisposed to developing the malignancy, scientists report in the January Cancer Prevention Research.
People with a rare hereditary condition called Gorlin syndrome develop hundreds or even thousands of basal cell carcinomas in a lifetime.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.